Stock Events

Stock Events

Shionogi &. 

$19.1
41
-$0.4-2.05% Thursday 13:30

Statistics

Day High
19.1
Day Low
19.1
52W High
26
52W Low
14.25
Volume
256
Avg. Volume
-
Mkt Cap
16.99B
P/E Ratio
15.16
Dividend Yield
1.17%
Dividend
0.22

Upcoming

30
SEP
Dividend Ex
Estimated
 
1
DEC
Dividend Payment
Estimated
 
31
MAR 27
Dividend Ex
Estimated
 
30
SEP 27
Dividend Ex
Estimated
 
1
DEC 27
Dividend Payment
Estimated
 

Dividends

1.17%Dividend Yield
Mar 26
$0.24
Dec 25
$0.22
Jun 25
$0.22
Dec 24
$0.39
Jun 24
$0.37
10Y Growth
0.85%
5Y Growth
-6.86%
3Y Growth
-13.31%
1Y Growth
4.39%

Earnings

12MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
0.28
0.38
0.47
0.56
Expected EPS
0.302272705238
Actual EPS
N/A

Financials

38.71%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
9.37BRevenue
3.63BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SGIOF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a global pharmaceutical company that competes with Shionogi in various therapeutic areas, including infectious diseases and vaccines.
Merck
MRK
Mkt Cap277.02B
Merck & Co. is a direct competitor in the pharmaceutical sector, particularly in the fields of infectious diseases and oncology, areas where Shionogi also operates.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline competes with Shionogi in the development and marketing of medications for infectious diseases, including HIV and respiratory infections.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in areas such as infectious diseases and mental health, overlapping with Shionogi's portfolio.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie competes with Shionogi in the pharmaceutical market, particularly in areas like virology, where both companies have significant investments.
Novartis
NVS
Mkt Cap279.67B
Novartis is a global healthcare company that competes with Shionogi in multiple therapeutic areas, including neuroscience and cardiovascular diseases.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca competes with Shionogi in areas such as infectious diseases and oncology, with both companies investing in research and development for new treatments.
Sanofi
SNY
Mkt Cap110.4B
Sanofi competes with Shionogi in the global pharmaceutical market, particularly in areas like vaccines and infectious diseases.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol Myers Squibb is a competitor in the pharmaceutical industry, focusing on areas like oncology and cardiovascular diseases, which are also of interest to Shionogi.
Roche
RHHBY
Mkt Cap328.49B
Roche Holding AG competes with Shionogi in the pharmaceutical and diagnostics sectors, particularly in oncology and infectious diseases.

About

There is no Profile data available for SH0.MU.
Show more...
CEO
Dr. Isao Teshirogi Ph.D.
Employees
4955
Country
Japan
ISIN
JP3347200002

Listings

MU
DE
SH0.MU
MU
DE
SH00.MU
STU
DE
SH0.STU
OTC Link
US
SGIOY

0 Comments

Share your thoughts

FAQ

What is Shionogi &. stock price today?▼
The current price of SGIOF is $19.1 USD — it has decreased by -2.05% in the past 24 hours. Watch Shionogi &. stock price performance more closely on the chart.
What is Shionogi &. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Shionogi &. stocks are traded under the ticker SGIOF.
What is Shionogi &. market cap?▼
Today Shionogi &. has the market capitalization of 16.99B
When is the next Shionogi &. earnings date?▼
Shionogi &. is going to release the next earnings report on May 12, 2026.
What were Shionogi &. earnings last quarter?▼
SGIOF earnings for the last quarter are 0.56 USD per share, whereas the estimation was 0.38 USD resulting in a +45.82% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Shionogi &. revenue for the last year?▼
Shionogi &. revenue for the last year amounts to 9.37B USD.
What is Shionogi &. net income for the last year?▼
SGIOF net income for the last year is 3.63B USD.
Does Shionogi &. pay dividends?▼
Yes, SGIOF dividends are paid semi-annual. The last dividend per share was 0.24 USD. As of today, Dividend Yield (FWD)% is 1.17%.
How many employees does Shionogi &. have?▼
As of May 06, 2026, the company has 4,955 employees.
In which sector is Shionogi &. located?▼
Shionogi &. operates in the Health & Wellness sector.
When did Shionogi &. complete a stock split?▼
The last stock split for Shionogi &. was on September 27, 2024 with a ratio of 3:1.
Where is Shionogi &. headquartered?▼
Shionogi &. is headquartered in Osaka, Japan.